GLOBAL ILEOSTOMY MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Global Ileostomy Market Size and Trends

Global ileostomy market is estimated to be valued at USD 1.90 Bn in 2024 and is expected to reach USD 3.15 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 7.5% from 2024 to 2031.

Discover market dynamics shaping the industry: Request sample copy

Growing aging population susceptible to diseases such as ulcerative colitis and Crohn's can boost demand for ileostomy products such as bags and accessories over the forecast period. Rising incidence of inflammatory bowel disease, intestinal cancer and trauma cases leading to adverse gastrointestinal conditions has increased the requirement for ileostomy surgeries globally. Moreover, various initiatives undertaken by public and private organizations to spread awareness about ostomy care and generate funds for research can drive the market growth.

Increasing Prevalence of Inflammatory Bowel Diseases

Rising number of people suffering from chronic intestinal conditions like Crohn's disease and ulcerative colitis has boosted demand for ileostomy procedures. Inflammatory bowel diseases cause long-lasting inflammation and ulcers in the digestive tract. While their exact causes are still unknown, genetics and environment are believed to play a role. Symptoms include severe abdominal pain, diarrhea, weight loss and fatigue. The psychological and physical toll of lifelong intestinal inflammation has intensified medical interest in identifying risk factors and biomarkers to better diagnose and treat these conditions. Several studies have linked smoking, appendectomy, diet and gut microbiome imbalances to IBD onset and progression. As research continues to unravel the multi-factorial contributions of lifestyle, genetics and gut microbes, the prevalence of IBD is expected to climb higher across populations undergoing nutrition transition and modern urbanization. More knowledge of disease triggers can pinpoint at-risk groups for careful monitoring and early intervention. This ensures steady demand for ileostomy supplies and stoma care products to manage the debilitating impacts of IBD on quality of life.

Market Concentration and Competitive Landscape

Get actionable strategies to beat competition: Request sample copy

Increasing number of colorectal cancer cases

Increasing number of colorectal cancer cases worldwide can drive the global ileostomy market growth. Colorectal cancer is one of the most commonly diagnosed cancers globally. According to the World Health Organization (WHO), in 2020, around 1.9 million new cases of colorectal cancer were reported worldwide. This number is expected to rise by 60% to over 3 million new cases by 2030. Permanent ileostomy is often required when part of the colon or rectum is surgically removed to treat colorectal cancer. When a section of the intestine is removed, the remaining portions must be reattached so that bowel movements can continue in a new way. An ileostomy allows bowel movements to pass through an opening in the abdomen called a stoma made during surgery. A pouch is placed over the opening to collect stool. Rising number of colorectal cancer cases leads to more patients requiring ileostomies, thus, boosting demand for ileostomy appliances used in their care. Growing aging population worldwide also contributes to rising prevalence of colorectal cancer and corresponding growth in the ileostomy market. Age is a significant risk factor for colorectal cancer, with over 90% of cases occurring in people over 50 years old. As life expectancy increases globally, more people are surviving to older ages where their risk for colon cancer is highest. According to the United Nations, the number of people aged 65 years and older is projected to increase from 727 million in 2020 to over 1.5 billion in 2050. Many countries now have "aging populations" with over 20% of their people aged 65 and over. This dramatic aging trend  will lead to rising need for ileostomy products and services.

Key Takeaways from Analyst:

Global ileostomy market growth is driven by rising cases of inflammatory bowel disease and colorectal cancer globally. North America dominates the ileostomy market, due to high awareness and supportive reimbursement policies for ostomy procedures in the region. Increasing number of surgeries for conditions like Crohn's disease and ulcerative colitis can drive the market growth. However, social taboos and stigma associated with ostomy pouches in some countries can hamper the market growth.

Asia Pacific offers promising growth opportunities for ileostomy bag manufacturers due to growing geriatric population, improving access to healthcare, and rising healthcare expenditure in China and India. The emergence of digitized platforms helps improve support systems for ostomy patients. Players are investing in custom-fit skin barriers and two-piece bags to increase comfort for wearers and reduce leakage issues. Increasing focus on educating medical practitioners about stoma care can help improve acceptance of ostomy procedures over time.

Manufacturers are developing innovative hydrocolloid-based pouches and accessories to provide discretion and improve adhesion. Growing popularity of non-invasive ostomy procedures presents an opportunity to delay definitive ostomies.

Market Challenges: High cost of ostomy surgeries and products

The high cost of ostomy surgeries and associated products can drive the global ileostomy market growth. Ostomy surgeries that involve formation of a stoma and diversion of the flow of bowel contents are often performed as a life-saving procedure for conditions like colorectal cancer, inflammatory bowel disease, and others.  However, these complex surgeries and the postoperative care are expensive.  The costs related to an ostomy do not end after the initial surgery. Patients require specialized ostomy pouches, wafers, irrigation systems and other accessories on an ongoing basis for effective ostomy management. While these products enhance the quality of life and empower ostomates, these come at a substantial recurring expenditure. According to the data published by the U.S. Agency for Healthcare Research and Quality in 2021, the average annual cost of ostomy supplies per person in the U.S. ranged from US$ 3,000 to US$,10,000 depending on the type of ostomy and individual requirements. This financial burden acts as a deterrent for optimal follow up and compliance to stoma care guidelines, compromising health outcomes. Poverty and lack of health insurance further shrink access to ostomy care, especially in developing nations. According to the data from World Bank, over 735 million people globally still do not have basic health coverage. Catastrophic health expenditure poses serious financial risks. Various international charities try to bridge the affordability gap through donation of supplies. However, the scale remains limited in comparison to the actual needs of the ostomate population worldwide.

Market Opportunities: Development of customized ostomy products

Development of customized ostomy products can offer opportunity for global ileostomy market growth. Currently available standard products are often not a good fit for all bodies and lifestyles, leading to frequent leaks, discomfort and embarrassment. Customized solutions tailored to each individual's anatomy, lifestyle and preferences have potential to drastically improve patients' quality of life. Several startups are currently working on 3D scanning and printing technology to design ostomy pouches and accessories customized for each person. This allows products to perfectly contour and seal around the stoma, with optimal cut-outs for hernias or other irregularities. Customization also extends to discretion and fashion - pouches can be constructed in various skin tones and under different garments. This helps boost patients' confidence and empower them to freely participate in all activities. The technology is continuously advancing to produce stronger, more flexible materials while maintaining an affordable cost. Rising awareness about such customized options can boost their demand. In 2021, according to the report published by the World Health Organization, over 2.5 million new cases of colorectal cancer were reported worldwide in 2020, and this figure will increase to 4 million new cases by 2040. Since ostomy surgery is a common treatment, the annual number of ileostomy procedures is bound to increase steadily.

Discover high revenue pocket segments and roadmap to it: Request sample copy

By Product Type- Convenience and discretion boosts adoption of bag

By product type, bags segment is estimated to contribute the highest market share of 59.7% in 2024, owing to convenience and discretion factors. Bags allow wearers to collect effluent discreetly without worrying about hygiene or clean-up, when away from home. The single-use, disposable nature of bags also means less cleaning and maintenance effort for wearers. Their versatility in size and material further enhance discretion and wearing comfort in different situations. Bags are also very convenient to use. These can simply be secured with an adhesive wafer and their tight seal prevents any leakages or odors. Users do not have to worry about emptying or changing them frequently unless filled. Integrated filters also lessen odor issues as compared to direct drainage into ostomy accessories. The ease of use has made bags a preferred first-line product for patients undergoing ostomy procedures. Physicians also routinely recommend bags initially as these involve less learning curve than accessories. Bags have addressed key user priorities of discretion and convenience better than any other ileostomy product type.

By Type- End procedure prevalence fuels end ileostomy segment

 By type, end ileostomy segment is estimated to contribute the highest market share of 55% in 2024, due to its higher prevalence over other types. End ileostomy involves diverting the small intestine to exit through an artificial opening in the abdominal wall. It remains the most common procedure performed for conditions requiring resection of the distal ileum or ileocecal junction. For example, in Crohn’s disease patients with severe inflammation at the end of the small bowel. Compared to other resections and anastomoses, an end ileostomy procedure has fewer technical difficulties and risk of post-op complications for surgeons. It also makes reconnection of bowel segments easier in future reversal surgeries compared to more extensive resections done in procedures like loop ileostomy. Due to such advantages, end ileostomy is utilized more frequently by clinicians regardless of the disease indication. The higher usage volume boosts demand for associated ileostomy products.

By Disease Type: Drainage options drive Crohn's disease segment

 By disease type, Crohn's disease segment is estimated to contribute the highest market share of  42% in 2024, since it requires drainage options. Crohn's can involve inflammation throughout the gastrointestinal tract unpredictably, from mouth to anus. Thus, managing effluent and enforcing rest for the diseased bowel is crucial but varies case-by-case. Ileostomy allows customized options like temporary or permanent drainage based on current and future disease prognosis, unlike other disease types. For complex Crohn's cases involving both small and large bowel, options like loop ileostomy letting both ends drain externally provides surgeons flexibility. This addresses important disease management goals for Crohn's like nutrition, medication delivery and rest therapy for inflamed bowels. The ability to tailor effluent routing makes ileostomy an important tool in treating Crohn's disease complications compared to other indications.

Regional Insights

To learn more about this report, Request sample copy

North America dominates the global ileostomy market with an estimated market share of 41.2% in 2024. The U.S. accounts for the largest share due to high prevalence of inflammatory bowel diseases and colorectal cancer in the country. As per estimates, over 1 million Americans suffer from ulcerative colitis and Crohn's disease.  Rising colorectal cancer cases has boosted demand for ostomy products and devices for disease management.

Presence of leading multinational companies in the U.S. can also drive the market growth. Well-established players such as Coloplast, ConvaTec, and Hollister have been operating in the country for decades. These offer diversified portfolio of ileostomy bags, accessories, and support services to cater to the needs of large patient base. The availability of different reimbursement options also facilitates higher product adoption.

Asia Pacific region is projected to witness the fastest growth during the forecast period. Rapid improvements in healthcare infrastructure and rising medical tourism can drive the market growth. In countries such as Japan, China and South Korea, growing geriatric population can boost demand for ostomy care solutions. Meanwhile, India is emerging as a major production hub for ostomy accessories due to availability of low-cost raw materials and labor. Several European and American companies have set up manufacturing facilities to leverage these advantages.

The growth prospects in Asia Pacific are also encouraging new players to enter the market. Both global and regional companies are expanding their footprint through strategic collaborations with local hospitals, distributors and support groups.

Market Report Scope

Global Ileostomy Industry News

• In April 2024, Convatec, a prominent global medical products and technologies company, introduced Esteem Body with Leak Defense in the U.S. This launch addresses the increasing adoption of soft convexity ostomy barriers, particularly post-surgery, driven by the rising prevalence of global obesity.
• In June 2021, Pelican Healthcare Ltd, strengthened its position in the U.K. and Ireland healthcare markets with the launch of the innovative ModaVi range of ostomy pouches

*Definition: Ileostomy market consists of medical products and devices designed for patients who have undergone an ileostomy procedure. An ileostomy involves bringing the end of the small intestine through an opening in the abdomen, so devices in this market help to collect and contain waste exiting the intestinal tract through this stoma. The key products in the ileostomy market include ostomy pouches, skin barriers and protective rings that attach to the skin around the stoma, as well as associated accessories like irrigation kits, deodorants, and adhesive removers. These products are essential for ileostomy patients to manage their condition and go about daily activities.

Market Segmentation

•  Product Type Insights (Revenue, USD Bn, 2019 - 2031)
  • Bags
    • One Piece
    • Two Piece
  • Accessories
    • Seals/Barrier Rings
    • Pouch Cover
    • Pouch Closures
    • Stoma Caps/Hat
    • Belts & Girdles
    • Adhesive Spray
    • Stoma Guards
    • Others
•  Type Insights (Revenue, USD Bn, 2019 - 2031)
  • End Ileostomy
  • Loop Ileostomy
•  Disease Type Insights (Revenue, USD Bn, 2019 - 2031)
  • Cancer
  • Crohn's Disease
  • Ulcerative Colitis
  • Others
•  End user Insights (Revenue, USD Bn, 2019 - 2031)
  • Home Care Settings
  • Hospitals
  • Ambulatory Surgery Centers
  • Academic & Research Institute
  • Others
• Regional Insights (Revenue, USD Bn, 2019 - 2031)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
  • Coloplast Corp
  • ConvaTec Inc.
  • Hollister Incorporated
  • Marlen Manufacturing & Development Company
  • Perma-Type Company, Inc.
  • Nu-Hope Laboratories, Inc.
  • Perfect Choice Medical Technologies
  • Fortis Medical Products
  • Safe n' Simple
  • AdvaCare Pharma
  • Schena Ostomy Technologies, Inc.
  • Cymed
  • TG Eakin Limited
  • Alcare Diagnostic Research Center Pvt. Ltd.
  • Welland Medical Limited